Cholesterol-lowering drugs given green light for NHS use 28/04/2021, 2:23 pm The National Institute for Health and Care Excellence has approved bempedoic acid with ezetimibe for NHS use (Julien Behal/PA) Thousands of patients with high cholesterol are set to benefit from a treatment after health officials said that it could be used in the NHS. Adults in England who have primary hypercholesterolaemia or mixed dyslipidaemia – also known as high cholesterol – will now be eligible for treatment with two new types of once-daily pills. The National Institute for Health and Care Excellence (Nice) has approved bempedoic acid with ezetimibe for NHS use for patients who have high levels of low-density lipoprotein cholesterol (LDL-C), also known as “bad” cholesterol, and are unable to take statins.